2025, No. 01
Published on:January 5, 2025
¥ 0 ¥ 0
2025,138(1):1-4 DOI: 10.1097/CM9.0000000000003359
Brain injury biomarkers and applications in neurological diseasesfree
2025,138(1):5-14 DOI: 10.1097/CM9.0000000000003061
2025,138(1):15-27 DOI: 10.1097/CM9.0000000000003230
Research progress on platelets in gliomafree
2025,138(1):28-37 DOI: 10.1097/CM9.0000000000003282
2025,138(1):38-40 DOI: 10.1097/CM9.0000000000003273
Hearing loss prevalence and burden of disease in China: Findings from provincial-level analysisfree
2025,138(1):41-48 DOI: 10.1097/CM9.0000000000003096
Needs for rehabilitation in China: Estimates based on the Global Burden of Disease Study 1990–2019free
2025,138(1):49-59 DOI: 10.1097/CM9.0000000000003245
2025,138(1):60-67 DOI: 10.1097/CM9.0000000000002994
2025,138(1):68-78 DOI: 10.1097/CM9.0000000000003261
2025,138(1):79-92 DOI: 10.1097/CM9.0000000000003186
2025,138(1):93-98 DOI: 10.1097/CM9.0000000000002966
Fecal siderophore genes are potential biomarkers for ulcerative colitisfree
2025,138(1):99-101 DOI: 10.1097/CM9.0000000000003424
2025,138(1):102-104 DOI: 10.1097/CM9.0000000000003377
2025,138(1):105-107 DOI: 10.1097/CM9.0000000000003367
2025,138(1):108-110 DOI: 10.1097/CM9.0000000000003343
2025,138(1):111-113 DOI: 10.1097/CM9.0000000000003353
Chimeric antigen receptor T cells targeting CD312 as a therapy for acute myeloid leukemiafree
2025,138(1):114-116 DOI: 10.1097/CM9.0000000000003362
Essential tremor plus affects disease prognosis: A longitudinal studyfree
2025,138(1):117-119 DOI: 10.1097/CM9.0000000000003340
2025,138(1):120-122 DOI: 10.1097/CM9.0000000000003337
Corrigendum: UBE2C affects breast cancer proliferation through the AKT/mTOR signaling pathwayfree
2025,138(1):67-67 DOI: 10.3760/cma.j.issn.0366-6999.2025.01.101
刊 期:中华医学杂志(英文版)2025年138卷01期
会员价:20元 原价:10 元
账户余额:20 元